Tuesday, November 26, 2024

DHA awards Pharmacy Data Transaction Service (PDTS) bridge in advance of recompete

Notice ID: JA-21-0180B

Contract: HHSN316201200013W

Pharmacy Data Transaction Services (PDTS) provides a data warehouse support of the Department of Defense TRICARE pharmacy program.  PDTS provides storage, retrieval and reporting functions for transaction and safety data associated with all prescriptions dispensed for TRICARE beneficiaries through retail pharmacies, Mail Order Pharmacy (MOP) and Military Treatment Facilities (MTF) pharmacies worldwide.

Pharmacy Operations Division (POD) was notified of additional requirements between February-March 2021 to include the use of Informatica for coding translation. Informatica, the established Extract Transfer Load (ETL) tool, was not available to the SCRA’s development team for several months after extension of the contract. DHA J6 requested new requirements for Informatica access in April 2021. This added an estimated 90 to 150 calendar days to the completion schedule. In addition, DHA J6 requested a new requirement for a full risk management framework (RMF) assessment and authorization (A&A) to obtain the Authority to Operate (ATO), resulting in an updated program schedule extending into January 2022.

This bridge action will provide 21 months (until March 31, 2023) of continued support beyond the current period of performance of the PDTS Data Warehouse to enable the requirement to be recompeted and transitioned out to a potential new awardee. The Government anticipates award of the follow-on requirement by 2Q22. Because of the volume of data required to transition, the requirements for systems…

CSRA is the current contractor performing data warehouse services. In accordance with (IAW) FAR 6.302-1(a)(2)(iii)(A-B), services may be deemed to be available only from the original source in the case of follow-on contracts for the continued provision of highly specialized services when it is likely that award to any other source would result in (A) substantial duplication of cost to the Government that is not expected to be recovered through competition or (B) unacceptable delays in fulfilling the agency’s requirements. The process of a new competition and contract award to a contractor who is not the incumbent will require a lengthy transition period (12 months or longer) including but not limited to additional stand up and migration and increased management, resulting in duplication of costs to the Government that is not expected to be recovered through competition and cause unacceptable delays. It is in the Government’s best interest to continue services with CSRA to not only avoid substantial duplication of efforts and costs and unacceptable delays, but also, to ensure services will continue without disruption until March 2023.

Read more here.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required